OPEN SOURCE PHARMA FOUNDATION
  • Home
  • About
    • History
    • Meet our team
    • Funders
    • OSPF-India >
      • Reports
  • Partners
  • Press
  • Achievements
  • Projects
    • All Projects
    • Publications
  • Ideas
    • COVID-19 Ideas
    • Other Ideas
  • Resources
  • Why We Need OSP
  • COVID-19 Response
    • Open Source COVID-19 Vaccine
    • Open Source COVID-19 Drugs: ​In Silico Drug Repurposing
    • OSP Idea Factory: C-19 Drug Discovery Hypotheses
    • Global Repurposing Platform COVID-19
    • Open Source COVID-19 Resources
  • Education
  • Events
  • Join
    • Volunteer
    • Contact us
  • Donate

Open Source COVID-19 Drugs:
​In Silico Drug Repurposing​

results
discussion

Project Description

This  crowdsourcing for open source COVID-19 drug repurposing research project can be broken down into the following steps:

A. Crowdsource to build a systems biology model for the virus, and for drug target identification
(i) Search literature, and characterize each of the proteins of SARS-CoV-2 (COVID_19), as well as their homologues.
(ii) Place all of these proteins in their functional context; namely, specific to the host target and its self-assembly.
(iii) Identify the most essential proteins as the specific targets of interest for therapeutic development (e.g., Spike Trimer, TMPRSS2, etc.).
(iv) Build InSilco 3D structures, based on homology modeling.
(v) Undertake molecular docking for each target.
(vii) Examine at the interacting surface of the spike trimmer protein and search for potential inhibitors.


B. Virus target on host receptor (ACE2) modeling.
(i) Identify all of the host receptor (ACE2) polymorphisms in the various populations profiled in the global each population human genome databases. Try to correlate these with the potential affinity variation with spike protein.
(ii) Search (in silico) for inhibitors that can block this interaction.
​

C. Host factors that can protect from the virus
(i) Various host miRNA and other variabilities that can target the virus RNA and block processing and/or degrade the viral RNA.
(ii) Determine what targets can reduce a cytokine storm.


Project conceptualized by and mentored by Professor Samir K. Brahmachari.
view Results

Join/ Contribute to this Project

VIEW results
Join the discussion
Picture
Picture
OSPF is a supporter of the Open Source Pharma Movement and Community
Our Locations:
OSPF NIAS Drug Discovery Lab
National Institute of Advanced Studies
Indian Institute of Science Campus
Main Block, F-24
Bangalore, KA 560012
​INDIA

OSPF-Paris
Centre de Recherches Interdiciplinaires
8bis Rue Charles V
Paris, 75004
FRANCE

OSPF-USA
188 Grand Street #236
New York, NY 10013
USA
​Registered Office:
Open Source Pharma Foundation
Manyata Tech Park
MFAR Green Heart Building, Level 7
Hebbal, Outer Ring Road
Bangalore, KA 560045 
INDIA 
​
OSPF-India

Contact:
+91 80 22185052 / +91 9880193120
​info@ospfound.org
Make a donation
  • Home
  • About
    • History
    • Meet our team
    • Funders
    • OSPF-India >
      • Reports
  • Partners
  • Press
  • Achievements
  • Projects
    • All Projects
    • Publications
  • Ideas
    • COVID-19 Ideas
    • Other Ideas
  • Resources
  • Why We Need OSP
  • COVID-19 Response
    • Open Source COVID-19 Vaccine
    • Open Source COVID-19 Drugs: ​In Silico Drug Repurposing
    • OSP Idea Factory: C-19 Drug Discovery Hypotheses
    • Global Repurposing Platform COVID-19
    • Open Source COVID-19 Resources
  • Education
  • Events
  • Join
    • Volunteer
    • Contact us
  • Donate